Literature DB >> 1345823

Th1 lymphokine production profiles of nickel-specific CD4+T-lymphocyte clones from nickel contact allergic and non-allergic individuals.

M L Kapsenberg1, E A Wierenga, F E Stiekema, A M Tiggelman, J D Bos.   

Abstract

Panels of nickel-specific T-lymphocyte clones (TLC) were prepared from nickel-allergic and non-allergic donors. TLC from both panels showed similar levels of expression of TCR alpha/beta, CD4, CD2, CD25, and CD29 and recognized nickel in association with class II HLA molecules with restriction determinants in HLA-DR, HLA-DP, and HLA-DQ. The lymphokine secretion was analyzed in TLC from both panels upon antigen-specific or non-specific stimulation and was compared with the secretion profiles of representants of pre-established human atopen-specific Th1 and Th2 cells. Nickel-specific TLC from both panels showed a lymphokine secretion pattern similar to the atopen-specific Th1 cells, although there was some variation from clone to clone. Most TLC secreted substantial amounts of IFN-gamma, IL-2, TNF-alpha, and GM-CSF, but little or no IL-4 and IL-5. The variation observed mainly concerned IL-2 secretion that could be low or absent in some of the TLC. The general secretion pattern did not change upon different modes of stimulation, including activation via CD3, CD2, or CD28. Because nickel-specific TLC from allergic and non-allergic individuals show a similar Th1 secretion pattern, the present results give no evidence that aberrant lymphokine secretion by CD4+T cells determines the contact allergic state, as was found for atopic allergy in a previous study.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1345823     DOI: 10.1111/1523-1747.ep12494841

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  23 in total

Review 1.  T cells in allergic responses to haptens and proteins.

Authors:  M L Kapsenberg; J D Bos; E A Wierenga
Journal:  Springer Semin Immunopathol       Date:  1992

2.  IL-12 gene expression in human skin-derived CD1a+ dendritic lymph cells.

Authors:  N Yawalkar; C U Brand; L R Braathen
Journal:  Arch Dermatol Res       Date:  1996-02       Impact factor: 3.017

Review 3.  [Contact dermatitis. II].

Authors:  P J Frosch; T Rustemeyer; A Schnuch
Journal:  Hautarzt       Date:  1996-12       Impact factor: 0.751

Review 4.  Cell and molecular biology of chemical allergy.

Authors:  I Kimber; R J Dearman
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

5.  Reduced production of both Th1 and Tc1 lymphocyte subsets in atopic dermatitis (AD).

Authors:  A Lonati; S Licenziati; A D Canaris; S Fiorentini; G Pasolini; M Marcelli; S Seidenari; A Caruso; G De Panfilis
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

Review 6.  Skin-homing T cells in human cutaneous allergic inflammation.

Authors:  L F Santamaria Babi; M T Perez Soler; C Hauser; K Blaser
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

7.  A critical role for thymic stromal lymphopoietin in nickel-induced allergy in mice.

Authors:  Meinar Nur Ashrin; Rieko Arakaki; Akiko Yamada; Tomoyuki Kondo; Mie Kurosawa; Yasusei Kudo; Megumi Watanabe; Tetsuo Ichikawa; Yoshio Hayashi; Naozumi Ishimaru
Journal:  J Immunol       Date:  2014-03-26       Impact factor: 5.422

Review 8.  Allergy and dermatophytes.

Authors:  Judith A Woodfolk
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

9.  Do patients with a failed metal-on-metal hip implant with a pseudotumor present differences in their peripheral blood lymphocyte subpopulations?

Authors:  Isabelle Catelas; Eric A Lehoux; Ian Hurda; Stephen J Baskey; Luca Gala; Ryan Foster; Paul R Kim; Paul E Beaulé
Journal:  Clin Orthop Relat Res       Date:  2015-09-01       Impact factor: 4.176

10.  Human T helper cells reactive with somatic bacterial antigens belong to the Th1 subset.

Authors:  J F Schlaak; P Nieder; K H Meyer zum Büschenfelde; B Fleischer
Journal:  Med Microbiol Immunol       Date:  1994-07       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.